Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined Restylane Defyne and Restylane Lyft for mandibular contour enhancement in Chinese adults
ChiCTR2500114030Phase 4Not yet recruiting
- Sponsor
- Tongji Hospital
- Start
- Dec 2025
- Modality
- Hydrogel Systems → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of nasha hyaluronic acid and Restylane Lyft in None, sponsored by Tongji Hospital. Primary endpoint: GJS improvement rate at 3 and 12 months vs baseline. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
nasha hyaluronic acidRestylane Lyft
Beyond the preview
Go deeper on ChiCTR2500114030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500114030.